Platform for a Technological Leap in Antibiotics

Biotechnet Switzerland

Authors

  • Elsbeth Heinzelmann

DOI:

https://doi.org/10.2533/chimia.2015.809

Keywords:

Antimicrobial-resistant organisms, Gram-negative bacteria, Klebsiella pneumoniae, Multidrug-resistant strains, Pathogenesis of tuberculosis

Abstract

NTN Swiss Biotech™ brings together the Swiss Biotech Association SBA, which is involved in regulatory, financial and legal issues, and biotechnet Switzerland, which is active in translational R&D, to provide a technology base for joint projects. Biotechnet aims to push promising domains by creating topic-oriented platforms that enable academia and industry to work together to produce R&D results of major importance to society and the economy. The first activity initiated by biotechnet is the Antibiotics Platform that has now been launched.
CHIMIA Vol. 69 No. 12 (2015): Energy Storage Research in Switzerland–The SCCER Heat & Electricity Storage

Downloads

Published

2015-12-16

Issue

Vol. 69 No. 12 (2015): Energy Storage Research in Switzerland–The SCCER Heat & Electricity Storage

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2015 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

[1]
E. Heinzelmann, Chimia 2015, 69, 809, DOI: 10.2533/chimia.2015.809.